Medicinal Cannabis Matters | Friday roundup 10th January 2025.
Medicinal Cannabis Matters | Friday roundup 10th January 2025
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
This week, we explore a study examining how medicinal cannabis is improving the lives of individuals with IBD, highlight its promising potential for relieving menstrual cramps, and share Lauren Thomas’s story as she reflects on her journey with medicinal cannabis and how it has helped her better manage her life.
A UK study finds that medicinal cannabis can help to improve the lives of those with IBD.
Patients with IBD have reported that medicinal cannabis may help manage symptoms and improve their quality of life. Findings from the current study align with previous research demonstrating the benefits of medicinal cannabis for individuals coping with IBD symptoms.
Medicinal cannabis shows promise for menstrual cramps.
A clinical trial has provided strong evidence supporting the effectiveness of managing menstrual cramps. The study reported consistent improvements, including significant pain relief and increased functionality.
Lauren Thomas from Lincolnshire recounts her journey with medicinal cannabis.
After years of struggling with severe anxiety, depression, and fibromyalgia, the 31-year-old shared that her life only began to improve when she started using medicinal cannabis. Now, she can travel for work and enjoy the activities she loves without her symptoms holding her back.
If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey, Guernsey and the Isle of Man. Check your eligibility today.
https://www.medicann.co.uk/book-consultation/eligibility/
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
